← 홈

프로그램 비교

검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일

현재 선택: 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV22행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
AntibodyPreclinical
blood sample (blood sample)
Institut du Cancer de Montpellier …·Tay-Sachs Disease Ganglioside
ORR 13%
Overview
Program
blood sample
Overview
Company
Institut du Cancer de Montpellier - Val d'Aurelle
Overview
Modality
ANTIBODY
Overview
Target
Tay-Sachs Disease Ganglioside
Overview
Indication
Breast Cancer
Overview
Phase
PRECLINICAL
Overview
Status
ACTIVE
MoA
Mechanism
targeting chimeric antigen receptor
MoA
Biomarker
biomarker of intestinal permeability in the allogeneic hematopoietic stem cell transplantation (allo-HSCT) se
PK/PD
Species
Mouse
PK/PD
Animal (cat.)
Mouse, In vitro
PK/PD
Experiment
pharmacokinetic
Toxicology
Species
Mouse
Toxicology
Animal (cat.)
Mouse, In vitro
Toxicology
Major finding
Diagnostic Value of Key Clinical Characteristics and Baseline Cortisol in Assessing Adrenal Function in Patients Receiving Glucocorticoid Therapy.. Prolonged glucocorticoid therapy may result in multi-organ complications and adrenal insufficiency (AI). To mitigate these risks, clinicians typically taper and discontinue treatment once the underlying disease is controlled. Prior to withdrawal, adren…
Toxicology
CRS
Reported
Clinical
Primary efficacy
ORR 13%
Clinical
ORR
13%
Clinical
Result source
ClinicalTrials.gov NCT00068341
Clinical
Data Tier / Score
A · 26
Clinical
Program phase
PRECLINICAL
Clinical
Clinical sync
2026년 7월 12일 (2일 전)